Senores Pharmaceuticals Ltd
BSE: 544319
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 36.81+28.0% | 28.76-18.6% | 35.33+78.3% | 19.82+67.1% | 11.86+23.7% | 9.59 |
| Other Income | 22.19+126.9% | 9.78-13.9% | 11.36+35.4% | 8.39-9.3% | 9.25+28.7% | 7.19 |
| Total Income | 59.00+53.1% | 38.54-17.5% | 46.69+65.5% | 28.21+33.6% | 21.11+25.8% | 16.78 |
| EXPENSES | ||||||
| Expenditure | 46.31+32.2% | 35.02-10.3% | 39.04+58.6% | 24.62+35.2% | 18.21+17.8% | 15.46 |
| Tax | 4.21+383.9% | 0.87-28.7% | 1.22+37.1% | 0.89+1.1% | 0.88+257.7% | 0.25 |
| PROFIT | ||||||
| PBT | 12.69+260.5% | 3.52-54.0% | 7.65+113.1% | 3.59+23.8% | 2.90+119.5% | 1.32 |
| Net Profit | 8.48+220.0% | 2.65-58.8% | 6.43+138.1% | 2.70+33.7% | 2.02+87.9% | 1.07 |
| KEY METRICS | ||||||
| OPM % | -9.45%-6.22pp | -3.23%-7.53pp | 4.30%+10.15pp | -5.85%+17.17pp | -23.02%+74.24pp | -97.26% |
| NPM % | 14.37%+7.49pp | 6.88%-6.89pp | 13.77%+4.20pp | 9.57% | 9.57%+3.16pp | 6.41% |
| EPS | 1.84-7.1% | 1.98+41.4% | 1.40+137.3% | 0.59+51.3% | 0.39+21.9% | 0.32 |
Corporate Events
Board MeetingSENORES
202627Jul
Board Meeting
The Board Meeting is scheduled to consider and approve the U…
BSE Filing ↗ Board MeetingSENORES
202629Jun
Board Meeting
The Board of Directors considered and approved the proposed …
BSE Filing ↗ Board MeetingSENORES
20256Nov
Board Meeting
Consider and approve Un-audited Standalone and Consolidated …
BSE Filing ↗ Board MeetingSENORES
202523Jan
Board Meeting
Consider and approve Unaudited Standalone and Consolidated F…
BSE Filing ↗